Your browser doesn't support javascript.
loading
Faster speed of onset of the depressive episode is associated with lower cytokine serum levels (IL-2, -4, -6, -10, TNF-α and IFN-γ) in patients with major depression.
Buspavanich, Pichit; Adli, Mazda; Himmerich, Hubertus; Berger, Maximilian; Busche, Marlene; Schlattmann, Peter; Bopp, Sandra; Bschor, Tom; Richter, Christoph; Steinacher, Bruno; Stoppel, Christian; Hindinger, Claudia; Meyer, Saskia; Hoffmann, Kai; Stamm, Thomas; Gabriel, Alexander; Merkl, Angela; Goerke-Arndt, Franziska; Köhler, Stephan; Sterzer, Phillip; Heinz, Andreas; Behr, Joachim; Fakhri, Hajar; Lang, Florian; Lang, Undine E; Ricken, Roland.
Afiliação
  • Buspavanich P; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Adli M; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany; Department of Psychiatry and Psychotherapy, Fliedner Klinik Berlin, Berlin, Germany.
  • Himmerich H; Department of Psychological Medicine, King's College London, London, United Kingdom; Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
  • Berger M; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Busche M; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Schlattmann P; Department of Statistics, Informatics and Data Science, Jena University Hospital, Jena, Germany.
  • Bopp S; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Bschor T; Department of Psychiatry and Psychotherapy, Technical University of Dresden Medical School, Dresden, Germany.
  • Richter C; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany; Department of Psychiatry and Psychotherapy, Vivantes Klinikum Kaulsdorf, Berlin, Germany.
  • Steinacher B; Department of Psychiatry and Psychotherapy, Vivantes Wenckebach-Klinikum, Berlin, Germany; Department of Psychiatry and Psychotherapy, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.
  • Stoppel C; Department of Psychiatry and Psychotherapy, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.
  • Hindinger C; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Meyer S; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Hoffmann K; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Stamm T; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Gabriel A; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Merkl A; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany; Department of Psychiatry and Psychotherapy, Fliedner Klinik Berlin, Berlin, Germany.
  • Goerke-Arndt F; Department of Psychiatry and Psychotherapy, Oberhavel-Kliniken, Henningsdorf, Germany.
  • Köhler S; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Sterzer P; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Heinz A; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Behr J; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Pot
  • Fakhri H; Department of Physiology, University of Tübingen, Tübingen, Germany.
  • Lang F; Department of Physiology, University of Tübingen, Tübingen, Germany.
  • Lang UE; Department of Psychiatry and Psychotherapy, University Psychiatric Clinics, Basel, Switzerland.
  • Ricken R; Department of Psychiatry and Psychotherapy, Charité -Universitätmedizin Berlin, Campus Mitte, Berlin, Germany. Electronic address: roland.ricken@charite.de.
J Psychiatr Res ; 141: 287-292, 2021 09.
Article em En | MEDLINE | ID: mdl-34271459
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Transtorno Depressivo Maior Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Psychiatr Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Transtorno Depressivo Maior Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Psychiatr Res Ano de publicação: 2021 Tipo de documento: Article